Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day.
In this interview, Petrovic explains why research wasn’t for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot.
In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday’s DeviceTalks Clubhouse series.
Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.